|
Clinical research and business development executive Irving Dark heads Cytel’s cutting-edge clinical trial design and implementation services to the biopharmaceutical industry. Mr. Dark brings to Cytel 15-years of management experience guiding drug, biologic and medical device products successfully through the development process, along with a proven record of growing commercial clinical research organizations. Prior to joining Cytel, Mr. Dark most recently served as Vice President, Business Development and Operations for Veristat, Inc. At Veristat he established and oversaw the company’s Data Management, Project Management, and Business Development departments. He was also integral to Veristat’s Corporate Compliance activities ensuring adherence to regulatory and GCP guidelines. Mr. Dark was actively involved with Veristat’s oncology, influenza, and smallpox vaccine program successes. Prior to Veristat, Mr. Dark held key positions at full-service trial leader PAREXEL managing phase 1 - 3 clinical trials in the US, South America, Europe and Asia. Mr. Dark has experience in statistical programming, data management, electronic data capture, international project management, and has accumulated an in-depth knowledge of the industry’s clinical development needs. He is the co-author of numerous published clinical studies and a recent DIA invited speaker. Mr. Dark received an Economics, BA in 1991 from the University of Rhode Island. | 